All prices include GST and are in NZ dollars

  • Managing Chronic Obstructive Pulmonary Disease (COPD)

    On Demand Respiratory System

    • $60.00 incl. GST for PSNZ members
    • $180.00 incl. GST for non-members

    Managing COPD is an interactive learning module designed to increase pharmacists’ knowledge, confidence and skills in the identification and management of patients with COPD. We have developed it in alignment with the NZ COPD Guidelines. At the completion of the course, you will be able to educate patients on evidence-based management of COPD and motivate them to engage in self-management practices.

    read more ≻

  • MAVIRET Quality Use of Medicines - On Demand

    Infections On Demand

    • $0.00 incl. GST for PSNZ members
    • $0.00 incl. GST for non-members

    MAVIRET® is a fully funded hepatitis C prescription medicine on the Pharmaceutical Schedule since February 2019.

    If you wish to dispense MAVIRET®, pharmacists are required to complete the College MAVIRET® Quality Use of Medicines training course and your pharmacy needs to be enrolled in the AbbVie Care Pharmacy Programme.

    read more ≻

  • Medicines Therapy Assessment (MTA) Portfolio

    Accreditation Course On Demand Pharmacy Services

    • $360.00 incl. GST for PSNZ members
    • $1,080.00 incl. GST for non-members

    The Medicines Therapy Assessment (MTA) is a systematic, patient-centred clinical assessment of all medicines currently taken by a patient, identifying, resolving and preventing medication-related problems as well as optimising the effectiveness of medication treatment.

    read more ≻

  • Medicines Use Review Accreditation Training Programme

    On Demand Pharmacy Services

    • $360.00 incl. GST for PSNZ members
    • $1,080.00 incl. GST for non-members

    The accreditation training programme needed to become accredited to undertake Medicines Use Reviews.

    read more ≻

  • Molnupiravir (Lagevrio) - what a pharmacist needs to know

    Infections On Demand

    • $0.00 incl. GST for PSNZ members
    • $180.00 incl. GST for non-members

    This course provides information about Molnupiravir (Lagevrio®) the evidence, mechanism of action, a discussion of safety concerns and the management of interactions and use in different populations. The supply and patient eligibility criteria are also discussed.

    read more ≻